Teva pharmaceutical industries limited TEVA.US Overview Analysis
)TEVA AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock, with its moderate value rating, suggests that existing positions can be retained. For initiating new positions, it's advisable to wait for a value score above 4 and a dividend score of 2 or higher.
TEVA Current Performance
-6.31%
Teva pharmaceutical industries limited
0.38%
Avg of Sector
-0.07%
S&P500
Top 10 High Relevance to TEVA
- BIOA Bioage labs incValue -Trend 3Swing Trading 2Whale Interest 2Dividend 1See more
TEVA Profile
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.